Merit Medical Systems, Inc.
NASDAQ:MMSIMedical - Instruments & Supplies
+$1.16 today
- Market cap
- $5.15B
- Beta
- 0.53
- P/E (TTM)
- 28.4
- EPS (TTM)
- $2.34
Volume 0.46M
Average 0.79M
MMSI Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Merit Medical Systems, Inc.NASDAQ: MMSI
Cost of Revenue · Q3 FY2026 · quarter ended Sep 2026
Cost of revenue grows in line with its trailing trend
Q3 FY2026 cost of revenue of $215.61M rose 9.0% year over year, ahead of the +7.2% change in trailing-twelve-month cost of revenue. Sequentially, it rose 5.9% from the prior quarter. Over 3 fiscal years it compounded at +7.2% a year.
Context
- Cost of revenue amounted to 51.3% of revenue in FY2025, down 1.2 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +9.0% holds above the trailing-twelve-month pace of +7.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 777.79M USD
- Year-over-year change
- +9.1%
- 4-year CAGR
- +7.2%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 777.79M | +9.1% |
| FY2024 | 2024-12-31 | 713.18M | +5.9% |
| FY2023 | 2023-12-31 | 673.49M | +6.6% |
| FY2022 | 2022-12-31 | 631.88M | +7.2% |
| FY2021 | 2021-12-31 | 589.42M | — |
Cost of Revenue vs competitors
How MMSI compares with its peers on the latest reported figures
- MMSI's LTM Sep 2026 cost of revenue of $815.11M is the 6th highest of the 10 companies compared; the peer median is $1.2B.
- Its year-over-year change of +7.2% is the 4th highest of 10, against a peer median of -1.3%.
- Cost of revenue amounts to 50.6% of revenue for MMSI, versus a peer median of 46.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $10.72B | -10.1% | -2.9% | 53.0% | |
| LTM Jun 2026 | $6.06B | -11.0% | +7.8% | 28.8% | |
| LTM Jun 2026 | $3.77B | -1.3% | +4.1% | 45.3% | |
| LTM Jun 2026 | $1.35B | -11.4% | -3.8% | 62.4% | |
| LTM Jun 2026 | $1.2B | -11.0% | -11.5% | 46.2% | |
| LTM Sep 2026 | $815.11M | +7.2% | +7.2% | 50.6% | |
| LTM Mar 2026 | $636.88M | +8.8% | +11.0% | 46.4% | |
| LTM Feb 2026 | $146.03M | +12.9% | -3.6% | 46.5% | |
| LTM Jun 2026 | $135.77M | +7.4% | +17.4% | 23.8% | |
| LTM Mar 2026 | $70.77M | +0.2% | +7.8% | 27.6% | |
| Peer median (excluding MMSI) | $1.2B | -1.3% | +4.1% | 46.2% | |
Competitors are the stored peer set for MMSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.07B | 1.15B | 1.26B | 1.36B | 1.51B |
| Cost of Revenue | 589.42M | 631.88M | 673.49M | 713.18M | 777.79M |
| Gross Profit | 485.33M | 519.1M | 583.87M | 643.33M | 736.94M |
| Gross Margin | 45.2% | 45.1% | 46.4% | 47.4% | 48.7% |
| Research & Development | 71.25M | 75.51M | 82.73M | 83.81M | 97.35M |
| Selling, General & Admin | 335.69M | 342.53M | 373.68M | 376.73M | 455.21M |
| Operating Expenses | 424.42M | 431.54M | 458.73M | 487.64M | 552.57M |
| Depreciation & Amortization | 95.78M | 92.2M | 101.29M | 114.73M | 134.65M |
| EBITDA | 154.96M | 181.17M | 228.89M | 273.97M | 332.05M |
| EBITDA Margin | 14.4% | 15.7% | 18.2% | 20.2% | 21.9% |
| Operating Income | 60.92M | 87.56M | 123.94M | 155.69M | 184.38M |
| Operating Margin | 5.7% | 7.6% | 9.9% | 11.5% | 12.2% |
| Interest Income | 769K | 439K | 2.46M | 26.23M | 15.07M |
| Interest Expense | 5.26M | 6.34M | 15.51M | 31.22M | 26.46M |
| Other Income / Expenses | (7M) | (4.93M) | (11.86M) | (5.7M) | (13.44M) |
| Income Before Tax | 53.92M | 82.63M | 112.09M | 149.99M | 170.94M |
| Pre-Tax Margin | 5.0% | 7.2% | 8.9% | 11.1% | 11.3% |
| Income Tax Expense | 5.46M | 8.11M | 17.68M | 29.64M | 42.45M |
| Net Income | 48.45M | 74.52M | 94.41M | 120.36M | 128.49M |
| Net Margin | 4.5% | 6.5% | 7.5% | 8.9% | 8.5% |
| EPS (Basic) | 0.86 | 1.31 | 1.64 | 2.07 | 2.17 |
| EPS (Diluted) | 0.84 | 1.29 | 1.62 | 2.03 | 2.13 |
| Weighted Avg Shares | 56.15M | 56.81M | 57.59M | 58.22M | 59.16M |
| Weighted Avg Shares (Diluted) | 57.36M | 57.67M | 58.36M | 59.37M | 60.46M |
Merit Medical Systems, Inc.
NASDAQ:MMSI
Intrinsic Alpha fair value
Locked
Current Price
$85.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.